Floatz logo

VODOBATINIB

Dementia With Lewy Bodies

Georgetown UniversitySmall moleculePhase 2Dormant
C
33/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
18/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Dementia With Lewy Bodies cohort.

Asset / SponsorPhaseRating
Namenda
Zealand University Hospital
Phase 4BBB
INTEPIRDINE
Axovant Sciences Ltd.
Phase 2/3BB
Armodafinil
NYU Langone Health
Phase 4BB
Irsenontrine
Eisai Inc.
Phase 2BB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BB

View all 33 →

Same molecule, other indications

VODOBATINIB is also rated in:

Parkinson diseaseDormant
C
Indicative ·
37 / 100
View asset →
chronic myeloid leukemiaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →